Docetaxel Injection, Solution
Product Images NDC 43598-389

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 43598-389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4carton (4carton)

Docetaxel Injection USP 80 mg/4 mL (20 mg/mL) intravenous injection solution carton from Dr. Reddy's Laboratories Inc. The label states it is for intravenous infusion only and indicates it is a single-dose 4 mL vial. It includes preparation instructions advising to add to infusion solution and warnings to use only the two-vial formulation. Packaging includes NDC 43598-259-40 and a barcode on one panel.*

FDA Label Image

4vial (4vial)

Docetaxel Injection USP 80 mg/4 mL (20 mg/mL) intravenous injection solution label by Dr. Reddy's Laboratories Inc. The label indicates it is a cytotoxic agent for intravenous infusion only, specifying contents of 20 mg docetaxel per mL. It lists inactive ingredients including polysorbate 80, dehydrated alcohol, and others, and includes the manufacturer address in Andhra Pradesh, India.*

FDA Label Image

8carton

Label for Docetaxel Injection, USP 160 mg/8 mL (20 mg/mL) intravenous infusion solution by Dr. Reddy's Laboratories Inc. The 8 mL single-dose vial label states it is ready to add to infusion solution and warns against using the two-vial formulation. Dosage details, handling instructions, storage conditions, and barcode are included.*

FDA Label Image

8vail

Label for Docetaxel Injection, USP 160 mg/8 mL (20 mg/mL) by Dr. Reddy's Laboratories Inc. The label states it is a one-vial formulation for intravenous infusion only, includes NDC 43598-389-57, and features a barcode with product identification details.*

FDA Label Image

Box (Box)

Text instructions for oral corticosteroid dosing related to docetaxel injection, specifying schedules for breast, non-small cell lung, stomach, head and neck cancers, and prostate cancer. The text includes spaces to record dates and times for doses around the three-week docetaxel injection treatment days.*

FDA Label Image

Carton (Carton)

Label for Docetaxel Injection USP 20 mg/mL, an intravenous infusion solution by Dr. Reddy's Laboratories Inc. It is a new concentration and preparation, ready to add to infusion solution. The label includes usage instructions, warnings against using the two-vial form with this one-vial product, dosage and administration notes, and packaging details for a 1 mL single-dose vial.*

FDA Label Image

Fig1 (Fig1)

A line graph depicting disease-free survival probability percentage over time in months. Two lines compare survival between groups labeled TAC and FAC, showing a decline in disease-free survival over approximately 66 months.*

FDA Label Image

Fig10 (Fig10)

A Kaplan-Meier survival curve graph showing survival probability over time (months) comparing two groups: TPF (n=255) and PF (n=246). The vertical axis represents survival probability in percentage, and the horizontal axis depicts survival time in months, with patient risk numbers at various time points below the graph.*

FDA Label Image

Fig2 (Fig2)

A survival probability chart comparing TAC and FAC regimens over a period of up to 66 months. The x-axis represents survival time in months, and the y-axis shows survival probability percentage. Two survival curves are displayed, one for TAC and one for FAC, indicating trends in survival rates over time.*

FDA Label Image

Fig3 (Fig3)

A survival curve chart comparing overall survival between two groups labeled T75 and BSC over survival time in months. The graph shows cumulative probability on the vertical axis and survival time in months on the horizontal axis, with a log-rank p-value of 0.010 indicated.*

FDA Label Image

Fig4 (Fig4)

A survival curve graph depicting overall survival probability over time in months, labeled with 'T75 V/I'. The y-axis shows cumulative probability from 0 to 1, and the x-axis indicates survival time in months from 0 to 21. The graph includes a log-rank p-value of 0.13 for comparison.*

FDA Label Image

Fig5 (Fig5)

A Kaplan-Meier survival curve graph showing survival probability on the y-axis versus survival time in months on the x-axis. Two groups are compared: T75 q3w (solid line) and M q3w (dotted line), illustrating differences in survival over a 30-month period.*

FDA Label Image

Fig6 (Fig6)

A Kaplan-Meier survival curve chart showing probability (%) on the y-axis and time in months on the x-axis. It compares two groups labeled TCF and CF, illustrating their survival probabilities over a 24-month period.*

FDA Label Image

Fig7 (Fig7)

A line graph depicting survival probability (%) over survival time in months. Two curves labeled TCF and CF show declining survival probabilities from 0 to 36 months, illustrating survival trends for two different treatments or groups.*

FDA Label Image

Fig8 (Fig8)

A Kaplan-Meier curve graph depicting Progression Free Survival (PFS) probability over time in months. The graph compares two groups labeled TPF (solid line) and PF (dashed line), showing the percentage of PFS decreasing as time progresses up to 42 months.*

FDA Label Image

Fig9 (Fig9)

A survival probability Kaplan-Meier curve graph showing survival time in months on the x-axis and survival probability percentage on the y-axis. Two survival curves are plotted and labeled as TPF and PF, illustrating differences in survival probabilities over a 72-month period.*

FDA Label Image

Structure (Structure)

Chemical structure of Docetaxel. The diagram displays the molecular framework including various rings, hydroxyl groups, ester groups, and other functional groups typical of the docetaxel compound.*

FDA Label Image

Vial (Vial)

Label for Docetaxel Injection USP 20 mg/mL solution for intravenous use, manufactured by Dr. Reddy's Laboratories Inc. The label indicates the product as a cytotoxic agent and includes concentration information, regulatory details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.